Skip to main content
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Mobius-Winkler S, Majunke N, Sandri M et al (2015) Percutaneous left atrial appendage closure: technical aspects and prevention of periprocedural complications with the watchman device. World J Cardiol 7:65–75CrossRefPubMedPubMedCentral Mobius-Winkler S, Majunke N, Sandri M et al (2015) Percutaneous left atrial appendage closure: technical aspects and prevention of periprocedural complications with the watchman device. World J Cardiol 7:65–75CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Gloekler S, Shakir S, Doblies J et al (2015) Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillation. Clin Res Cardiol 104(8):656–665CrossRefPubMed Gloekler S, Shakir S, Doblies J et al (2015) Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillation. Clin Res Cardiol 104(8):656–665CrossRefPubMed
3.
Zurück zum Zitat Seeger J, Bothner C, Dahme T et al (2016) Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk. Clin Res Cardiol 105:225–229CrossRefPubMed Seeger J, Bothner C, Dahme T et al (2016) Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk. Clin Res Cardiol 105:225–229CrossRefPubMed
4.
Zurück zum Zitat Viles-Gonzalez JF, Kar S, Douglas P et al (2012) The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy. J Am Coll Cardiol 59:923–929CrossRefPubMed Viles-Gonzalez JF, Kar S, Douglas P et al (2012) The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy. J Am Coll Cardiol 59:923–929CrossRefPubMed
6.
Zurück zum Zitat Saia F, Martinez C, Gafoor S et al (2015) Long-term outcomes of percutaneous paravalvular regurgitation closure after transcatheter aortic valve replacement: a multicenter experience. JACC Cardiovasc Interv 8:681–688CrossRefPubMed Saia F, Martinez C, Gafoor S et al (2015) Long-term outcomes of percutaneous paravalvular regurgitation closure after transcatheter aortic valve replacement: a multicenter experience. JACC Cardiovasc Interv 8:681–688CrossRefPubMed
7.
Zurück zum Zitat Smolka G, Pysz P, Jasinski M et al (2015) Multiplug paravalvular leak closure using Amplatzer Vascular Plugs III: a prospective registry. Catheter Cardiovasc Interv. doi:10.1002/ccd.25992 PubMed Smolka G, Pysz P, Jasinski M et al (2015) Multiplug paravalvular leak closure using Amplatzer Vascular Plugs III: a prospective registry. Catheter Cardiovasc Interv. doi:10.​1002/​ccd.​25992 PubMed
Metadaten
Titel
Percutaneous closure of an incomplete left atrial appendage closure
verfasst von
Manuel Viehmann
Ingo Dähnert
Gerhard Schuler
Marcus Sandri
Publikationsdatum
01.04.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 9/2016
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-016-0982-0

Weitere Artikel der Ausgabe 9/2016

Clinical Research in Cardiology 9/2016 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.